Zymvol Biomodeling SL is a privately held biotech company dedicated to amplifying biocatalytic solutions in the market through cloud-based computer simulations.
ZYMVOL can help you:
- Improve the performance of enzymes to meet precise industrial requirements
- Identify the right enzyme to replace unsustainable chemical processes/products
- Find new gainful applications for biocatalysts
- Speed up and increase the success rate of focused and/or directed evolution
- Achieve considerable savings in investment and reagents,
- Reduce lab to market time
- Improve enzymes that do not have automatized laboratory screening processes
- Perform quick and inexpensive probing of new potential enzymes
For more information, please visit www.zymvol.com or contact us at info@zymvol.com
For more information about our Social Media Data Policy, please visit https://zymvol.com/privacy-policy/
ZYMVOL can help you:
- Improve the performance of enzymes to meet precise industrial requirements
- Identify the right enzyme to replace unsustainable chemical processes/products
- Find new gainful applications for biocatalysts
- Speed up and increase the success rate of focused and/or directed evolution
- Achieve considerable savings in investment and reagents,
- Reduce lab to market time
- Improve enzymes that do not have automatized laboratory screening processes
- Perform quick and inexpensive probing of new potential enzymes
For more information, please visit www.zymvol.com or contact us at info@zymvol.com
For more information about our Social Media Data Policy, please visit https://zymvol.com/privacy-policy/
Location: Spain, Catalonia, Barcelona
Employees: 11-50
Total raised: $4.54M
Founded date: 2017
Investors 2
| Date | Name | Website |
| 10.04.2026 | Unreasonab... | unreasonab... |
| 25.02.2023 | Elaia Part... | elaia.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 20.02.2025 | - | $3.15M | - |
| 21.02.2023 | - | $1.39M | - |
Mentions in press and media 17
| Date | Title | Description |
| 12.08.2026 | How research partnerships under the MSCA are driving innovation | Companies that receive funding from the EU’s Marie Skłodowska-Curie Actions (MSCA) can take part in initiatives that have a major impact on innovation – in some instances securing nearly one patent per funded project. Over the past 30 years... |
| 29.05.2025 | Barcelona's Masia Fund: Igniting the Tech Revolution | Barcelona is on the brink of a tech renaissance. The launch of the Masia angel fund marks a pivotal moment in this vibrant city’s journey to becoming a European tech powerhouse. Founded by Carlos Trenchs and Pepe Borrell, Masia aims to inje... |
| 26.05.2025 | New angel fund ‘Masia’ aims to cement Barcelona’s tech hub status | A new angel fund, Masia, has launched in Barcelona. Founded by VC Carlos Trenchs and Pepe Borrell, former co-founder of Crowdcube Europe, Masia aims to accelerate the city’s ascent as a premier European tech hub. The fund, which has operate... |
| 21.02.2025 | ZYMVOL: Pioneering the Future of Sustainable Enzymes | In the heart of Barcelona, a biotech revolution is brewing. ZYMVOL, a company founded in 2017, is on a mission to transform industries through the power of enzymes. Recently, they secured €3 million in seed funding, led by Faber Ventures, w... |
| 20.02.2025 | BioTech startup ZYMVOL raises €3 million for the use of sustainable enzymes | Barcelona-based ZYMVOL, a BioTech company on a mission to democratise the use of improved, sustainable enzymes throughout various industries, has raised Seed funding of €3 million. The funding was led by VC firms Faber Ventures (lead invest... |
| 20.02.2025 | ZYMVOL raises €3M for computational enzyme discovery and design | ZYMVOL, a biotech company focused on computational enzyme discovery and design has raised €3 million Seed funding led by Faber alongside Elaia Partners (existing Pre-Seed investor), and Übermorgen Ventures. Since its founding in 2017, ZYMVO... |
| 20.02.2025 | The Week in AgriFoodTech: Spore.Bio bags $23m for rapid on-site microbiology testing, Imperia raises $10.5m | This week French startup Spore.Bio raised a $23 million Series A to expand its rapid, on-site microbiology testing capabilities, Spain’s Imperia raised $10.5 million to expand its supply chain management SaaS platform across Europe, and Ham... |
| 17.01.2024 | Zymvol obtiene un préstamo de €700.000 de Avançsa | 17/01/2024 Nota de prensa ZYMVOL OBTIENE UN PRÉSTAMO DE €700.000 DE AVANÇSA Avançsa firmó, a finales de 2023, un acuerdo con Zymvol, empresa tecnológica especializada en el diseño y desarrollo de enzimas, fundada en 2017. Gracias a su métod... |
| 21.02.2023 | Zymvol raises €1.3 million to spread enzymes everywhere | Barcelona-based Zymvol wants to spread enzymes. Everywhere. From the pharma industry to the chemical and food industries enzymes, and the discovery and widespread usage thereof is big business. In order to facilitate the improved and sustai... |
| - | El CDTI otorga la subvención Neotec a 9 startups IQS Tech Factory | Ocho de las empresas subvencionadas han participado en las pasadas ediciones de IQS Next Tech, el primer programa de aceleración industrial de España |
Show more